This content is machine translated Cardiovascular risk and obesity Pathomechanisms, secondary prevention and treatment options Obesity is not only a well-known, significant risk factor for the development and progression of cardiovascular disease (CVD), but is also recognized as a disease entity in its own right...… CME-Test
View Post 4 min This content is machine translated CHD: Management after revascularization Individualization of antithrombotic therapy Coronary heart disease (CHD) is one of the most common heart diseases worldwide and is currently grouped into two syndromes: acute coronary syndrome (ACS) and chronic coronary syndrome (CCS). Following...…
View Post 9 min This content is machine translated Venous thromboembolism prevention PCSK9 inhibitors: Current evidence, mechanisms and unanswered questions Venous thromboembolism (VTE), consisting of deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third most common cause of cardiovascular mortality worldwide after myocardial infarction and stroke. Despite continuous...…
View Post 5 min This content is machine translated Acute heart failure Diuretic therapy for decongestion – what are the “unmet needs”? Acute heart failure is a life-threatening condition. According to current guideline recommendations of the European Society of Cardiology (ESC), drug therapy after acute decompensation should be implemented while the patient...…
View Post 2 min This content is machine translated CFTR modulators and biologics More attention for neurocognitive side effects CFTR modulators and biologics have had a significant impact on the treatment of cystic fibrosis and severe asthma in recent years. Despite all the benefits that these active substances bring,...…
View Post 11 min This content is machine translated Characteristics, prognosis and different evolutionary paths Progression of chronic heart failure Despite numerous scoring systems, estimating the prognosis of chronic heart failure (HF) is a major challenge. The MECKI score is an established tool for risk assessment, but usually only takes...…
View Post 5 min This content is machine translated SGLT2 inhibitors and GLP1-RA Are old, white men favored? Despite consistent recommendations and growing clinical evidence, uptake of SGLT2i and GLP1 RA therapies in people with type 2 diabetes and cardiorenal comorbidities has been slow. There is also relatively...…
View Post 5 min This content is machine translated Sarcoidosis, echinococcosis & Co. Suspected symptoms and differential diagnoses At the congress of the German Society for Pneumology and Respiratory Medicine (DGP), which took place in Leipzig this year, the poster sessions were dominated by exciting case studies. Some...…
View Post 4 min This content is machine translated Type 2 diabetes: PAD and diabetic foot syndrome Prevention is better than cure – don’t miss the risk foot Arteriosclerosis, the cause of peripheral arterial occlusive disease (PAOD), is a build-up of plaque in the arteries. Elevated blood sugar levels in the context of diabetes damage the arteries and...…
View Post 4 min This content is machine translated Heart failure Gradually expand drug therapy! Chronic heart failure mainly occurs in older people. The drug therapy options available today represent a decisive advance in treatment options. According to current ESC guideline recommendations, it is advisable...…
View Post 15 min This content is machine translated Current status and future prospects Cell and gene therapies in modern cardiology Cell and gene therapies are considered highly innovative but also challenging approaches in modern cardiology. While early hopes for adult stem cells from bone marrow or skeletal muscle were largely...…
